Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a government funding lapse notice and NIH operating status update, and the site revision has been updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.2%

- Check12 days agoChange DetectedAdded a Show glossary option and updated UI labels (including capitalization of QC metadata) with a revision bump from v3.3.4 to v3.4.0. These are minor editorial updates that do not change core study content or data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange Detected- Expanded and reorganized the Locations section to include a comprehensive list of study sites across multiple countries and U.S. states. - Previous grouped location headings were removed.SummaryDifference2%

- Check69 days agoChange DetectedMinor version update from v3.3.1 to v3.3.2 with no visible changes to study content.SummaryDifference0.0%

- Check76 days agoChange DetectedA new note states that publications are automatically filled from PubMed and may or may not be about the study. The page revision was updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.